Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
5.39
-0.11 (-2.00%)
Aug 15, 2025, 9:35 AM - Market open

Serina Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
6.043.677.620.530.31
Short-Term Investments
----1
Cash & Short-Term Investments
6.043.677.620.531.31
Cash Growth
-0.38%-51.80%1331.53%-59.41%-
Receivables
----0
Prepaid Expenses
1.771.93-0.020.02
Other Current Assets
0.180.08---
Total Current Assets
7.995.687.620.551.33
Property, Plant & Equipment
0.951.051.350.310.51
Total Assets
8.946.728.970.861.84
Accounts Payable
1.710.740.580.140.15
Accrued Expenses
1.311.430.580.010.01
Current Portion of Leases
0.180.190.250.130.21
Current Unearned Revenue
---0.15-
Other Current Liabilities
0.37--0.010
Total Current Liabilities
3.562.371.410.440.37
Long-Term Debt
--2.981.62-
Long-Term Leases
0.190.270.460.060.19
Other Long-Term Liabilities
3.553.58-1.080.95
Total Liabilities
7.36.224.863.191.51
Common Stock
00-0.020.02
Additional Paid-In Capital
52.4444.960.880.650.64
Retained Earnings
-55.58-44.32-33.18-38.45-35.76
Total Common Equity
-3.140.64-32.29-37.78-35.11
Minority Interest
-0.16-0.13---
Shareholders' Equity
1.650.514.11-2.340.33
Total Liabilities & Equity
8.946.728.970.861.84
Total Debt
0.360.463.71.810.4
Net Cash (Debt)
5.683.213.92-1.280.91
Net Cash Growth
--18.17%---
Net Cash Per Share
0.600.440.53-0.600.43
Filing Date Shares Outstanding
10.259.938.792.222.14
Total Common Shares Outstanding
10.159.422.472.222.14
Working Capital
4.433.316.210.110.96
Book Value Per Share
-0.310.07-13.09-17.03-16.37
Tangible Book Value
-3.140.64-32.29-37.78-35.11
Tangible Book Value Per Share
-0.310.07-13.09-17.03-16.37
Machinery
1.090.970.870.380.37
Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q